Join Us for a Special Virtual Event: Curing with Sound
- Details
In light of today's challenging times and to comply with appropriate social distancing procedures, the Foundation is offering a special virtual event on Thursday, April 9, at 2pm Eastern time.
Foundation Chairman, Neal F. Kassell, MD, will discuss the state of focused ultrasound for a variety of medical disorders and provide an overview of the Foundation's efforts to accelerate this revolutionary therapy.
Focused ultrasound is an early-stage, noninvasive therapeutic technology with the potential to transform the treatment of many devastating medical disorders, including Alzheimer's disease, cancer, Parkinson's disease, and more. The Focused Ultrasound Foundation is committed to making this revolutionary therapy available to countless patients in the shortest time possible.
This virtual event will use Zoom to connect attendees from across the globe, and there will be a live Q&A session following the presentation.
Complete instructions will be emailed to you upon registering.
We encourage you to share the registration link below with family, friends, and colleagues who may be interested in learning more about focused ultrasound. 
Neal F. Kassell, MD
Chairman, Focused Ultrasound Foundation
Special Virtual Event
Curing with Sound
Thursday, April 9, 2020
2:00 PM Eastern
About the Speaker
Neal F. Kassell, MD, is the founder and chairman of the Focused Ultrasound Foundation.
He was a Professor of Neurosurgery at the University of Virginia from 1984 until 2016 and was the Co-Chairman of the department until 2006. Before moving to Charlottesville in 1984, Dr. Kassell was on the faculty at the University of Iowa for seven years. He received both his undergraduate and medical education at the University of Pennsylvania and completed his MD in 1972. After internship and two years of neurology and neurosurgery residency in Philadelphia, Dr. Kassell completed his neurosurgical training with Dr. Charles Drake at the University of Western Ontario in 1977.
In April 2016, Dr. Kassell was appointed by Vice President Joe Biden to the National Cancer Institute’s Blue Ribbon Panel for Cancer Moonshot Initiative. He served as a member of the Global Future Council on Neurotechnologies and Brain Science for the World Economic Forum from 2016 - 2018. Dr. Kassell has served on many standing and ad hoc committees of the National Institutes of Health and in an editorial capacity for a variety of academic journals. He has contributed more than 500 publications and book chapters to the literature. Dr. Kassell is a member of numerous medical societies in the United States and abroad.
Dr. Kassell was a founder of Interax, Inc., the Virginia Neurological Institute, Multimedia Medical Systems, Inc., the Neuroclinical Trials Center, the NeuroVenture Fund, MedSpecialists.net, and the Focused Ultrasound Foundation. He has served on a number of public and private sector boards, including Eclypsis Corporation, INC Research, the Prostate Cancer Foundation, Virginia National Bank, INSIGHTEC, Inc., The Lagesse Foundation, and Expedition Trust Company. He is a shareholder of INSIGHTEC, Inc.
Community Mourns Passing of Focused Ultrasound Pioneer, Charles Cain
- Details
Professor Charles Cain, PhD, passed away on March 27, 2020, at the age of 77, after a three-year battle with prostate cancer.
Now Accepting Applications for Global Internships
- Details
Histotripsy-induced Immune Response
- Details
An international collaborative group based at the University of Michigan sought to determine whether histotripsy could create an anti-tumor immune response to melanoma or hepatocellular carcinoma in mice. Besides stimulating tumor-specific immune responses that appeared to synergize with checkpoint-based immunotherapeutics, their technique also may have created a systemic immune response that shrunk secondary untreated tumors and inhibited growth of pulmonary metastases.See Journal for ImmunoTherapy of Cancer >